Beneficial alteration of blood biochemical parameters by Telmisartan-Pioglitazone combination in rat
Background: It is very rare nowadays that type-2 diabetes mellitus patient is not having mild to moderate level of hypertension. In spite of having best medical therapies to control blood glucose level, diabetic patients suffer from poorer cardiovascular outcomes than nondiabetic individuals. Althou...
Main Authors: | Ibrahim, Fuzianna, Sengupta, Pinaki, Das, Arindam |
---|---|
Format: | Conference or Workshop Item |
Language: | English |
Published: |
2016
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/52139/ http://irep.iium.edu.my/52139/7/52139.pdf |
Similar Items
-
Safety profiling of pioglitazone and telmisartan combination by sub-chronic toxicity study in rat
by: Sengupta, Pinaki, et al.
Published: (2016) -
Development and validation of a LC- MS/MS Method for simultaneous quantitation of telmisartan and pioglitazone in rat plasma
by: Das, Arindam, et al.
Published: (2016) -
Assessment of preclinical pharmacokinetics and acute toxicity of pioglitazone and telmisartan combination
by: Sengupta, Pinaki Ranjan, et al.
Published: (2017) -
Development and validation of a high throughput LC–MS/MS method for simultaneous quantitation of pioglitazone and telmisartan in rat plasma and its application to a pharmacokinetic study
by: Sengupta, Pinaki, et al.
Published: (2017) -
Metabolomic analysis and biochemical changes in the urine and serum of streptozotocin-induced normal- and obese-diabetic rats
by: Mediani, Ahmed, et al.
Published: (2018)